Benign Prostatic Hyperplasia Treatment Market Size, Trends, Growth & Outlook

Benign Prostatic Hyperplasia Treatment Market - By Treatment Type (Drug Class, Minimally Invasive Surgeries, Laser Therapy, Others), By End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others) & Global Region - Market Size, Trends, Opportunity, Forecast 2019-2027

Industry: Life Science | Report ID: FAMI-00735 | Published on: Jan, 2020 | View: 303 | Share:         

Request Sample Enquire Before Buying Request Discount

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

  • Report Descripton
  • Table Of Content
  • Request Methodology
  • Request Customization

This study aims to provide a detailed analysis of the global benign prostatic hyperplasia treatment market along with qualitative trends for the year 2019. Further, the report also offers future trends and market forecast upto 2027.

The study includes the benign prostatic hyperplasia treatment market size and forecast for the global benign prostatic hyperplasia treatment market through 2027, segmented by treatment type, end user and region type as follows:

Benign Prostatic Hyperplasia Treatment Market, By Treatment Type:
• Drug Class
o Alpha-Blockers
o 5-Alpha-reductase Inhibitor (5-ARIs)
o Phosphodiesterase-5 Enzyme Inhibitor
o Others

• Minimally Invasive Surgeries
o Transurethral resection of the prostate (TURP)
o Transurethral incision of the prostate (TUIP)
o Transurethral microwave thermotherapy (TUMT)
o Prostatic Urethral lift
o Robotic Surgeries
o Others

• Laser Therapy
• Others

Benign Prostatic Hyperplasia Treatment Market, By End-user:
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

An in-depth analysis of the regional market scenario of the industry offers detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa) along with the coverage of major countries in each region.

Benign Prostatic Hyperplasia Treatment Market, By Region:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Global benign prostatic hyperplasia treatment market size has been derived using both primary interviews and secondary research. The research process starts with exhaustive secondary research using internal and external sources to obtain various qualitative and quantitative market insights related to the benign prostatic hyperplasia treatment market. Also, multiple primary interviews were conducted with industry experts in order to validate data and analysis. Primary interview sources include industry expert such as VPs, Marketing Directors business development managers, market intelligence managers, and country sales managers, and key opinion leaders specializing in the benign prostatic hyperplasia treatment market.

Some of the features of “Benign Prostatic Hyperplasia Treatment Market Report: Market Size, Trends, Opportunity, Forecast 2019-2027” include:

Market Size: Global benign prostatic hyperplasia treatment market size estimation in terms of value (USD Million)

Forecast Analysis: Market forecast (2019-2027) by application and distribution channel

Segmentation Analysis: Global benign prostatic hyperplasia treatment market value by various segments such as treatment type, end user in terms of value

Regional Analysis: Global benign prostatic hyperplasia treatment market split by North America, Europe, Asia Pacific, Latin America and Middle East & Africa

Growth Opportunities: Analysis on growth opportunities in different segments and regions of benign prostatic hyperplasia treatment market

Strategic Analysis: This section offers insights on merger and acquisition activities, new product development, and competitive landscape of benign prostatic hyperplasia treatment in the global benign prostatic hyperplasia treatment market
Analysis of competitive intensity of the industry on the basis of Porter’s Five Forces model

Key Questions Answered in this Report:

What are the most promising and high-growth trends in the global benign prostatic hyperplasia treatment market?

What are the key factors impacting market dynamics? What are the growth drivers, and restraints in benign prostatic hyperplasia treatment market?

What are the emerging industry trends in benign prostatic hyperplasia treatment market?

What are recent developments in the benign prostatic hyperplasia treatment market? Which companies are leading these industry activities?

What merger & acquisition activities have occurred in the past 3 years and what is its impact on the benign prostatic hyperplasia treatment industry?

Get a sample pages of this report Click here

Research Methodology

Market Definition and List of Abbreviations

1. Executive Summary
2. Growth Drivers & Issues in Global Benign Prostatic Hyperplasia Treatment Market
3. Global Benign Prostatic Hyperplasia Treatment Market Trends
4. Opportunities in Global Benign Prostatic Hyperplasia Treatment Market
5. Recent Industry Activities, 2019
6. Porter's Five Forces Analysis
7. Market Value Chain and Supply Chain Analysis
8. Global Benign Prostatic Hyperplasia Treatment Market Size (USD Million), Growth Analysis and Forecast, (2019 - 2027)

9. Global Benign Prostatic Hyperplasia Treatment Market Segmentation Analysis, By Treatment Type
9.1. Introduction
9.2. Market Attractiveness, By Treatment Type
9.3. BPS Analysis, By Treatment Type
9.4. Drug Class
9.4.1. Alpha-Blockers
9.4.2. 5-Alpha-reductase Inhibitor (5-ARIs)
9.4.3. Phosphodiesterase-5 Enzyme Inhibitor
9.4.4. Others
9.5. Minimally Invasive Surgeries
9.5.1. Transurethral resection of the prostate (TURP)
9.5.2. Transurethral incision of the prostate (TUIP)
9.5.3. Transurethral microwave thermotherapy (TUMT)
9.5.4. Prostatic Urethral lift
9.5.5. Robotic Surgeries
9.5.6. Others
9.6. Laser Therapy
9.7. Others

10. Global Benign Prostatic Hyperplasia Treatment Market Segmentation Analysis, By End-user
10.1. Introduction
10.2. Market Attractiveness, By End-user
10.3. BPS Analysis, By End-user
10.4. Hospitals
10.5. Ambulatory Surgical Centers
10.6. Specialty Clinics
10.7. Others

11. Geographical Analysis
11.1. Introduction
11.2. North America Benign Prostatic Hyperplasia Treatment Market Size (USD Million), 2019 - 2027
11.2.1. By Treatment Type
11.2.2. By Gender
11.2.3. By Nature
11.2.4. By Distribution Channel
11.2.5. By Country
11.2.5.1. Market Attractiveness, By End-user
11.2.5.2. BPS Analysis, By End-User
11.2.5.3. U.S. Market Size (USD Million), 2019 - 2027
11.2.5.4. Canada Market Size (USD Million), 2019 - 2027

11.3. Europe Benign Prostatic Hyperplasia Treatment Market Size (USD Million), 2019 - 2027
11.3.1. By Product Type
11.3.2. By End-user
11.3.3. By Country
11.3.3.1. Market Attractiveness, By Country
11.3.3.2. BPS Analysis, By Country
11.3.3.3. Germany Market Size (USD Million), 2019 - 2027
11.3.3.4. United Kingdom Market Size (USD Million), 2019 - 2027
11.3.3.5. France Market Size (USD Million), 2019 - 2027
11.3.3.6. Italy Market Size (USD Million), 2019 - 2027
11.3.3.7. Spain Market Size (USD Million), 2019 - 2027
11.3.3.8. Russia Market Size (USD Million), 2019 - 2027
11.3.3.9. Rest of Europe Market Size (USD Million), 2019 - 2027

11.4. Asia Pacific Benign Prostatic Hyperplasia Treatment Market Size (USD Million), 2019 - 2027
11.4.1. By Product Type
11.4.2. By End-user
11.4.3. By Country
11.4.3.1. Market Attractiveness, By Country
11.4.3.2. BPS Analysis, By Country
11.4.3.3. China Market Size (USD Million), 2019 - 2027
11.4.3.4. India Market Size (USD Million), 2019 - 2027
11.4.3.5. Japan Market Size (USD Million), 2019 - 2027
11.4.3.6. South Korea Market Size (USD Million), 2019 - 2027
11.4.3.7. Indonesia Market Size (USD Million), 2019 - 2027
11.4.3.8. Taiwan Market Size (USD Million), 2019 - 2027
11.4.3.9. Australia Market Size (USD Million), 2019 - 2027
11.4.3.10. New Zealand Market Size (USD Million), 2019 - 2027
11.4.3.11. Rest of Asia Pacific Market Size (USD Million), 2019 - 2027

11.5. Latin America Benign Prostatic Hyperplasia Treatment Market Size (USD Million), 2019 - 2027
11.5.1. By Product Type
11.5.2. By End-user
11.5.3. By Country
11.5.3.1. Market Attractiveness, By Country
11.5.3.2. BPS Analysis, By Country
11.5.3.3. Brazil Market Size (USD Million), 2019 - 2027
11.5.3.4. Mexico Market Size (USD Million), 2019 - 2027
11.5.3.5. Rest of Latin America Market Size (USD Million), 2019 - 2027

11.6. Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Size (USD Million), 2019 - 2027
11.6.1. By Product Type
11.6.2. By End-user
11.6.3. By Country
11.6.3.1. Market Attractiveness, By Geography
11.6.3.2. BPS Analysis, By Geography
11.6.3.3. GCC Market Size (USD Million), 2019 - 2027
11.6.3.4. North Africa Market Size (USD Million), 2019 - 2027
11.6.3.5. South Africa Market Size (USD Million), 2019 - 2027
11.6.3.6. Rest of Middle East & Africa Market Size (USD Million), 2019 - 2027

12. Competitive Landscape
12.1. Abbott
12.2. Astellas Pharma
12.3. Boehringer Ingelheim GmbH
12.4. Pfizer
12.5. Teva Pharmaceutical Industries
12.6. Merck & Co.
12.7. Teleflex Incorporated
12.8. Endo International Plc
12.9. Urologix
12.10. LISA Laser

Select License Type
  • Single User License $3840 USD
  • Multi-User License $5370 USD
  • Corporate User License $6450 USD

Our Clients

  • +1 518-300-1215Mon-Fri, 24Hrs
  • [email protected]We reply within an hours
  • Albany,
    NY, USA.